Goldman Sachs’s Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 NFYS.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-319,774
Closed -$11.2K 6183
2024
Q2
$11.2K Hold
319,774
﹤0.01% 5539
2024
Q1
$16K Hold
319,774
﹤0.01% 5410
2023
Q4
$16K Hold
319,774
﹤0.01% 5460
2023
Q3
$22.4K Hold
319,774
﹤0.01% 5345
2023
Q2
$13.9K Hold
319,774
﹤0.01% 5572
2023
Q1
$38.4K Hold
319,774
﹤0.01% 5588
2022
Q4
$22.4K Hold
319,774
﹤0.01% 5688
2022
Q3
$29K Hold
319,774
﹤0.01% 5873
2022
Q2
$51K Hold
319,774
﹤0.01% 6022
2022
Q1
$90K Hold
319,774
﹤0.01% 6139
2021
Q4
$157K Buy
+319,774
New +$166K ﹤0.01% 5995

Other funds holding NFYS.WS

Goldman Sachs's NFYS.WS Position: Q3 2024 in Review

Goldman Sachs sold out of Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (NFYS.WS) in Q3 2024, closing a stake of 319,774 shares — an estimated $11.2K sold.

Goldman Sachs first reported a position in NFYS.WS in Q4 2021 and held it in 11 quarters. The position peaked at $157K in Q4 2021. 5 funds tracked by Wall St. Rank hold NFYS.WS as of Q3 2024.

  • Goldman Sachs reported no remaining Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2024 after selling out during the quarter.
  • Goldman Sachs sold 319,774 Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2024, an estimated $11.2K.
  • Goldman Sachs first reported a position in Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2021 and held it in 11 quarters.
  • Goldman Sachs's Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $157K in Q4 2021.
  • 5 funds tracked by Wall St. Rank held Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2024.

Based on Goldman Sachs's 13F filing for Q3 2024, filed 14 Nov 2024.